SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 141 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $9,478,000 | -2.0% | 2,139,488 | +3.3% | 0.00% | -50.0% |
Q3 2016 | $9,669,000 | -22.0% | 2,070,506 | +9.8% | 0.00% | 0.0% |
Q2 2016 | $12,395,000 | +7.3% | 1,886,538 | +3.8% | 0.00% | 0.0% |
Q1 2016 | $11,556,000 | +6.6% | 1,816,958 | +1.1% | 0.00% | 0.0% |
Q4 2015 | $10,840,000 | +2.5% | 1,797,639 | +1.7% | 0.00% | 0.0% |
Q3 2015 | $10,571,000 | -20.7% | 1,767,660 | -9.3% | 0.00% | 0.0% |
Q2 2015 | $13,324,000 | +4.1% | 1,947,882 | -7.6% | 0.00% | 0.0% |
Q1 2015 | $12,795,000 | -10.9% | 2,107,907 | +1.7% | 0.00% | 0.0% |
Q4 2014 | $14,366,000 | -10.3% | 2,073,032 | +5.4% | 0.00% | -33.3% |
Q3 2014 | $16,009,000 | +2.6% | 1,966,696 | +2.5% | 0.00% | 0.0% |
Q2 2014 | $15,606,000 | +8.3% | 1,919,503 | +4.4% | 0.00% | +50.0% |
Q1 2014 | $14,410,000 | -9.5% | 1,838,020 | +2.1% | 0.00% | -33.3% |
Q4 2013 | $15,925,000 | +5.1% | 1,799,401 | -0.5% | 0.00% | 0.0% |
Q3 2013 | $15,150,000 | +6.9% | 1,807,832 | -4.9% | 0.00% | 0.0% |
Q2 2013 | $14,177,000 | – | 1,900,397 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |